[Correlation between plasma level of homocysteine and cerebral large-artery atherosclerosis]

Gui-hong Wang1, Yong-jun Wang, Yao He

  • 1Department of Neurology, Beijing Tiantan Hospital, Capital University of Medical Science, Beijing 100050, China. guihongw@126.com

Zhonghua Nei Ke Za Zhi
|December 15, 2006
PubMed

Insights

High plasma homocysteine is an independent risk factor for cerebral large-artery atherosclerosis in ischemic stroke patients. This risk is amplified by hypertension, older age, and low HDL cholesterol levels.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Clinical Biochemistry

Background:

  • Ischemic stroke is a leading cause of disability and mortality worldwide.
  • Cerebral large-artery atherosclerosis is a major contributor to ischemic stroke.
  • Identifying modifiable risk factors is crucial for stroke prevention.

Purpose of the Study:

  • To determine if elevated plasma homocysteine is an independent risk factor for cerebral large-artery atherosclerotic stenosis.
  • To assess the association between homocysteine levels and stroke severity.
  • To investigate the interaction of homocysteine with conventional risk factors.

Main Methods:

  • A cohort of 276 adult ischemic stroke patients undergoing digital subtraction angiography (DSA) was studied.
  • Patients were categorized into those with significant large-artery stenosis (>50%) and controls.
  • Plasma homocysteine levels and conventional stroke risk factors were analyzed.

Main Results:

  • High plasma homocysteine (>15 micromol/L) was significantly more prevalent in patients with atherosclerotic stenosis (38.8% vs. 15.4%).
  • Multivariable analysis confirmed homocysteine as an independent risk factor (OR 4.10, P=0.001).
  • The association was stronger with hypertension (OR 4.89), older age (OR 4.79), and low HDL (OR 10.46).

Conclusions:

  • Elevated plasma homocysteine is an independent risk factor for cerebral large-artery atherosclerosis.
  • The impact of homocysteine on stroke risk is potentiated by the presence of other risk factors like hypertension and dyslipidemia.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...